| 05/05/2026 5:06 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/29/2026 5:04 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/27/2026 11:58 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/23/2026 6:20 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/15/2026 5:57 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/10/2026 8:58 AM | Amundi (1330387) Filed by Sanofi (1121404) Subject | Form SCHEDULE 13G/A | |
| 03/31/2026 11:19 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/24/2026 10:57 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/10/2026 9:40 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/04/2026 11:26 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/03/2026 5:15 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for SNY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter.
|
| 02/23/2026 8:19 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/17/2026 12:28 PM | Sanofi (1121404) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/17/2026 11:34 AM | Sanofi (1121404) Filer | Form 20-F Registration statement / Annual report / Transition report | |
| 02/17/2026 11:44 AM | Sanofi (1121404) Filer | Form IRANNOTICE | |
| 02/17/2026 8:33 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/12/2026 8:17 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/11/2026 7:47 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 02/10/2026 8:18 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/10/2026 5:06 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 02/06/2026 9:09 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/05/2026 5:17 AM | Sanofi (1121404) Filer | Form S-8 POS | |
| 01/30/2026 6:55 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 01/29/2026 7:56 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/28/2026 5:37 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 01/23/2026 8:58 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/16/2026 5:02 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/12/2026 5:11 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T | |
| 01/09/2026 5:09 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 3:42 PM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 3:44 PM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-C | |
| 12/29/2025 5:22 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 5:23 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/23/2025 8:52 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/22/2025 11:25 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/15/2025 9:17 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/12/2025 11:26 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/03/2025 10:30 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/18/2025 11:29 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/14/2025 4:34 PM | Amundi (1330387) Filed by Sanofi (1121404) Subject | Form SCHEDULE 13G/A | |
| 11/04/2025 9:51 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
|
| 11/03/2025 10:40 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/31/2025 12:48 PM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/29/2025 10:15 AM | Sanofi (1121404) Filer | Form 424B5 | |
| 10/28/2025 9:57 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/27/2025 8:12 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 8:13 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 8:15 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 8:17 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 8:20 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 7:32 AM | Sanofi (1121404) Filer | Form 424B5 | |
| 10/27/2025 6:56 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/24/2025 5:20 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/24/2025 5:03 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/15/2025 11:07 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/26/2025 8:41 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/22/2025 1:59 PM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/17/2025 11:03 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/04/2025 11:55 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/03/2025 11:44 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/29/2025 9:36 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/31/2025 10:33 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/31/2025 7:06 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/31/2025 6:34 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/30/2025 7:09 AM | Sanofi (1121404) Filer | Form N-PX Annual Report of Proxy Voting Record of Registered Management Investment Company | |
| 07/29/2025 11:18 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 07/22/2025 7:49 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/18/2025 5:03 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/17/2025 5:04 AM | Blueprint Medicines Corp (1597264) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 07/10/2025 5:04 AM | Blueprint Medicines Corp (1597264) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 07/02/2025 7:25 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/27/2025 3:49 PM | Sanofi (1121404) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
| 06/24/2025 7:31 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/18/2025 5:43 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/17/2025 7:33 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/17/2025 5:07 AM | Blueprint Medicines Corp (1597264) Subject Sanofi (1121404) Filed by | Form SC TO-T | |
| 06/06/2025 10:35 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/02/2025 4:11 PM | Blueprint Medicines Corp (1597264) Subject Sanofi (1121404) Filed by | Form SC TO-C | |
| 06/02/2025 5:09 AM | Blueprint Medicines Corp (1597264) Subject Sanofi (1121404) Filed by | Form SC TO-C | |
| 06/02/2025 5:07 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/30/2025 9:51 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/22/2025 7:09 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/21/2025 9:55 AM | Sanofi (1121404) Filer | Form SD Specialized Disclosure Report | |
| 05/12/2025 3:50 PM | Amundi (1330387) Filed by Sanofi (1121404) Subject | Form SCHEDULE 13G/A | |
| 05/06/2025 5:15 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 05/05/2025 12:12 PM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |